From February's performance report released by major multinational companies in the world, although 2011 was a remarkable year for global chemical development, the industry still maintained a high profit. This is mainly due to the emerging, special and innovative engines that were launched several years ago. Multinational companies have remained cautiously optimistic about the prospects for this year: Although the market is difficult to improve in the first quarter, it is firmly believed that the second half of the year will usher in a turning point.
The series of earthquakes in Japan, the turmoil in North Africa, the continued development of the European debt crisis, the downgrade of US sovereign debt, the global consumer and investor confidence frustration, and the unfavorable factors such as high prices of raw materials and primary products fluctuate, have caused the world economy to recover by twists and turns. Against this backdrop, large chemical companies, with unremitting efforts, are moving toward the goals set at the beginning of 2011 and have made gratifying achievements.
The financial report released by the Bayer Group on February 28 showed that sales in 2011 increased by 4.1% to 36.528 billion euros; EBIT increased by 52.0% to 4.149 billion euros, both reaching new highs. BASF announced on February 27 that compared with 2010, company sales increased by 15% to 73.5 billion euros; EBIT increased by nearly 11% to 8.6 billion euros. Dow announced its 2011 results in early February: Its annual operating income reached a record of US$60 billion, an increase of 12% compared to the previous year. Sales figures, after deducting the effect of the divestment, increased by 18% compared to last year. Dow Corning's 2011 sales reached 6.43 billion U.S. dollars, a record high, up 7% from the previous year, mainly in Asia, Eastern Europe and developing regions. Celanese annual financial data show that 2011 net sales of 6.763 billion US dollars, an increase of 14% over the previous year, achieving a record performance.
In addition, companies such as Air Liquide, Michelin, Clariant, Suez Environment, and PolyOne have performed well and both achieved sales and profit growth.
Foresighted multinational companies adjusted their development strategies as early as a few years ago, shifted their investment focus to emerging countries and regions, and responded to global climate, energy, population, and environmental challenges, built on their strengths and avoided assets, operated assets, strengthened innovation, and developed downstream. As a high-tech company with advantages and characteristics, it has achieved continuous growth in its performance.
BASF's strategy of “creating new roles in chemistry†pursues profitable growth. According to this strategy, BASF will focus on the Asia-Pacific region, especially the Chinese market, and continue to invest in Greater China. It has also received substantial returns. Greater China sales in 2011 exceeded 6.5 billion euros, a record high. BASF also increased the production of specialty chemicals. Sales of specialty products increased by 28% for the year to 15.7 billion euros.
Last year Dow Chemical sold more than $19 billion in new areas, setting a new record, with sales in the Asia Pacific region exceeding US$10 billion for the first time; the company created its annual EBITDA history The record business segments include electronic and functional materials business, agricultural business, functional materials business, and raw materials and energy business. Celanese completed the acquisition of some assets of Ashland's two product lines, supporting the strategic growth of the company's polymer emulsion business.
Bayer defines emerging markets as Asia (excluding Japan), Latin America, Eastern Europe, Africa and the Middle East. In 2011, sales in emerging markets amounted to 13.29 billion Euros. Sales increased by 9.0% over the previous year and accounted for total sales of the Group. 36.4%. The growth momentum derives from significant progress in the field of innovation; Bayer now has four types of drugs in the late stages of R&D, all of which have the potential to revolutionize the market and have professional and advanced development in new materials, crop protection and seed technology. line.
PolyOne spun off the SunBelt chlor-alkali business in 2011 and acquired Carlsberg, the Brazilian company of Uniplen and global leader in additive and liquid colorant technology, ushering in an important turning point in its specialization process.
In 2012, the international economic situation is even more complicated. The “World Economic Situation and Prospects for 2012†report issued by the United Nations at the beginning of this year pointed out that the economies of developed economies are mired in a quagmire, and that emerging economies cannot do their own thing. In addition to the high international oil prices brought about by the recent Iranian nuclear crisis, uncertainties have increased. Some chemical companies have made cautious expectations for this year's outlook.
BASF’s annual report looks forward to 2012: If the average Brent crude oil price is US$110 per barrel and the global economic growth maintains 2.7% of the previous year's level, the global chemical production value will increase steadily by 4.1%. BASF Executive Board Chairman Dr. Bokeci said: “We believe that the global economy will grow slowly in the early part of 2012, and will accelerate afterwards. However, the serious sovereign debt crisis, especially the European and US debt crisis, makes the economic outlook uncertain, and the economic development. It has an adverse effect; the growth momentum of the chemical industry still mainly comes from emerging markets."
Dow Chong, chairman and chief executive of Dow Chemical, said: “We will continue to pay close attention to the global economic development trend. It is expected that the difficulties faced by Western Europe will continue in the near term; it is expected that there will be no substantial improvement in the market situation in the first quarter of this year. However, we are convinced that the economy will gradually recover in the second half of the year. In this situation, our focus will be mainly on implementation, and we will continue to strive to achieve Dow's growth goals."
Dr. Daix, CEO of Bayer Group, is full of confidence in the future development of the company: “Bayer Group expects overall sales growth in 2012 to be about 3%, and EBITDA will achieve a small increase, mainly due to the growth of the healthcare and crop science business; The current market situation is difficult, and the benefits of materials technology may be equal to 2011."
Magnesium Ascorbyl Phosphate,Phosphate Magnesium Powder,Ascorbic Acid Magnesium Phosphate Powder,Ascorbic Acid Magnesium Phosphate
JINGJIANG HENGTONG BIO-ENGINEERING CO.,LTD , https://www.jjhtbio.com